Noticias de ATHE_US

Noticias del mercado

Últimas noticias sobre ATHE_US — 148 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: ATHE_US ✕ 148 resultados
11/05/2026 ATHE_US — newsline.com
ATHE Alterity releases quarterly earnings with no revenue or EPS data disclosed; investors await more details.
11/05/2026 ATHE_US — Newser
ATHE Alterity releases quarterly earnings with no revenue or EPS data disclosed; investors await more details. - Annual Earnings Summary
11/05/2026 ATHE_US — Yahoo Finance
Alterity Therapeutics Announces Publication Demonstrating the Utility of Quantitative MRI as a Biomarker for Multiple System Atrophy
11/05/2026 ATHE_US — Stock Titan
MRI scan tracks brain iron to distinguish MSA from Parkinson’s
11/05/2026 ATHE_US — Newser
ATHE Alterity releases quarterly earnings with no revenue or EPS data disclosed; investors await more details.
10/05/2026 ATHE_US — MarketScreener
Alterity Therapeutics Says Peer-Reviewed Study Validates its Approach to Multiple System Atrophy; Shares Fall 9%
10/05/2026 ATHE_US — MarketScreener
Alterity Therapeutics : Announces Publication Demonstrating the Utility of Quantitative MRI as a Biomarker for Multiple System Atrophy
07/05/2026 ATHE_US — The Manila Times ES ← EN
Alterity Therapeutics realizará presentaciones en múltiples conferencias médicas en mayo de 2026

MELBOURNE, Australia y SAN FRANCISCO, 7 de mayo de 2026 (GLOBE NEWSWIRE) – Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (

07/05/2026 ATHE_US — Stock Titan
Three cities, one MSA program: Alterity lines up May presentations
07/05/2026 ATHE_US — The Manila Times
Alterity Therapeutics to Deliver Presentations at Multiple Medical Conferences in May 2026

MELBOURNE, Australia y SAN FRANCISCO, 7 de mayo de 2026 (GLOBE NEWSWIRE) – Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (

07/05/2026 ATHE_US — Stock Titan
Alterity Therapeutics (NASDAQ: ATHE) highlights MSA program at key May 2026 medical meetings
07/05/2026 ATHE_US — Yahoo Finance
Alterity Therapeutics to Deliver Presentations at Multiple Medical Conferences in May 2026

MELBOURNE, Australia y SAN FRANCISCO, 7 de mayo de 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” o “la Compañía”), una empresa de biotecnología dedicada al desarrollo de tratamientos modificadores de enfermedades neurodegenerativas, anunció hoy que las presentaciones relacionadas con el programa de desarrollo de la compañía en atrofia sistémica múltiple (MSA) se realizarán en múltiples conferencias médicas en mayo. 2026. Sociedad Internacional de Resonancia Magnética en Medicina 202

05/05/2026 ATHE_US — MSN
Alterity Therapeutics Limited - Depositary Receipt (ATHE) price target increased by 18.07% to 3.98
04/05/2026 ATHE_US — news.google.com
CCORF Maintains ALTERITY THERAPEUTICS LIMITED(PRNAF.US) With Buy Rating, Maintains Target Price $0.01
02/05/2026 ATHE_US — Seeking Alpha
Alterity Therapeutics Limited (ATHE) Discusses Phase II Data and Development Strategy for ATH434 in Multiple System Atrophy - Slideshow (NASDAQ:ATHE) 2026-05-02
01/05/2026 ATHE_US — MSN ES ← EN
Alterity Therapeutics Limited - El precio objetivo del recibo de depósito (ATHE) disminuyó un 35,66% a 4,27

Alterity Therapeutics Limited - Depositary Receipt (ATHE) price target decreased by 35.66% to 4.27

01/05/2026 ATHE_US — MSN
Alterity Therapeutics Limited - Depositary Receipt (ATHE) price target decreased by 35.66% to 4.27
01/05/2026 ATHE_US — MSN
Alterity Therapeutics Limited - Depositary Receipt (ATHE) price target increased by 18.07% to 3.98
30/04/2026 ATHE_US — The Manila Times ES ← EN
Alterity Therapeutics publica el Apéndice 4C: informe trimestral de flujo de efectivo y actualización corporativa del tercer trimestre del año fiscal 26

Alterity Therapeutics Releases Appendix 4C - Q3 FY26 Quarterly Cash Flow Report & Corporate Update

30/04/2026 ATHE_US — Yahoo Finance Australia
Alterity Therapeutics Releases Appendix 4C – Q3 FY26 Quarterly Cash Flow Report & Corporate Update

Página 3 de 8

keyboard_arrow_up